CardiAQ Valve Technologies (CVT) Discloses Successful Results of Acute In Vivo Study of Its Novel Transcatheter Mitral Valve Implantation (TMVI) System

WINCHESTER, Mass.--(BUSINESS WIRE)--Transcatheter heart valve company CardiAQ Valve Technologies (CVT), which is developing the world’s first self-conforming and self-anchoring technology for Transcatheter Mitral Valve Implantation (TMVI), announced today that successful results of an acute in vivo study of its TMVI system were disclosed by Dr. Joseph Bavaria during the “Mitral Valve Therapies Prior to and in Human Investigation” program at the “Transcatheter Cardiovascul

For more information, please visit
http://www.businesswire.com/news/home/20090928005116/en

You need to login to post comments.

Feed last updated 1969/12/31 @7:00 PM

0 COMMENTS:

VOCAPIA and SYSTRAN demonstrate an automated speech translation solution at EUROSATORY 2016 - GlobeNewswire (press release) views: 1540

Instagram is adding automatic in-app text translation - The Verge views: 1528

Here’s a ‘Brand-New’ Massive Multilingual Dataset for Machine Translation views: 1524

F.A.Q. | Terms and conditions